Tsunoda M, Mizuno K, Matsubara T
Department of Orthopaedic Surgery, Kobe University School of Medicine.
Kobe J Med Sci. 1993 Feb;39(1):35-50.
This study was conducted to provide further evidence of the inherent osteogenic potential of the fracture hematoma. The fracture hematoma was separated into its cellular and extracellular elements. The hematoma cells were cultured to study bone formation by the cellular elements alone. Bone formation acceleration factor was added to the cultured fracture hematoma cells. The cell responded to this stimulation by differentiation into chondrocytes. Fracture hematoma was freeze-dried to study the presence of osteoinduction by the extracellular factors in the fracture hematoma. The freeze-dried fracture hematoma was packaged in methylmethacrylate pellets and within capsules of hydroxyapatite. These pellets and capsules in response to extracellular humoral factors from the freeze-dried fracture hematoma. The results of experimental implantation of the cultured fracture hematoma cells revealed that these cells had the potential to differentiate into chondroblasts or osteoblasts when bone induction factors and bone acceleration factor was added to their media. These extracellular humoral factors are known to be present in the fracture hematoma.
本研究旨在为骨折血肿固有的成骨潜能提供进一步证据。将骨折血肿分离为细胞成分和细胞外成分。培养血肿细胞以单独研究细胞成分的骨形成情况。向培养的骨折血肿细胞中添加骨形成加速因子。细胞通过分化为软骨细胞对这种刺激做出反应。将骨折血肿冻干以研究骨折血肿中细胞外因子的骨诱导作用。将冻干的骨折血肿包装在聚甲基丙烯酸甲酯小球和羟基磷灰石胶囊中。这些小球和胶囊对来自冻干骨折血肿的细胞外体液因子做出反应。培养的骨折血肿细胞实验性植入的结果表明,当向其培养基中添加骨诱导因子和骨加速因子时,这些细胞具有分化为成软骨细胞或成骨细胞的潜能。已知这些细胞外体液因子存在于骨折血肿中。